Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021;8(4):589-601.
doi: 10.3233/JND-200614.

Oral and Swallowing Abilities Tool (OrSAT) for Type 1 SMA Patients: Development of a New Module

Affiliations

Oral and Swallowing Abilities Tool (OrSAT) for Type 1 SMA Patients: Development of a New Module

Beatrice Berti et al. J Neuromuscul Dis. 2021.

Abstract

We describe the development of a new tool specifically designed to record oral abilities, swallowing and, more generally, feeding in young type 1 SMA patients, to be used during the first 24 months of life.The tool is composed by a checklist and a separate section summarizing the functional abilities into levels of feeding/swallowing impairment. The checklist includes 12 questions assessing aspects thought to be clinically meaningful for a type 1 SMA population and developmentally appropriate for infants during the first months of life. Each item is graded with a score of 0 or 1, depending on the child's ability to perform the activity. As some items are age-dependent, the number of items to be used, and therefore the maximum score, changes with increasing age. The levels of feeding/swallowing impairment include four levels that can be identified using easily identifiable clinical criteria.In an attempt to validate the tool in an untreated population we applied it to 24 type 1 SMA patients (age range: 2.3-24.1 months, mean: 10.8) in whom the same information collected by the new tool had been previously recorded using a less-structured format.When patients were classified in three groups according to the Dubowitz decimal classification, there was a significant difference both at baseline and at follow-up (p < 0.001). The items assessing fatigue during the nursing sessions were the most frequently impaired even in infants who did not have any other obvious clinical sign of swallowing difficulties.

Keywords: Spinal muscular atrophy; dysphagia; oral motor function; swallowing; type 1 SMA infants.

PubMed Disclaimer

Conflict of interest statement

Eugenio Mercuri has received funding as a member of advisory boards for SMA studies for Scholar Rock, AveXis, Biogen, Ionis Pharmaceuticals, Inc., Novartis, and Roche; principal investigator for ongoing Ionis Pharmaceuticals, Scholar Rock, Inc./Biogen and Roche clinical trials; funding from Famiglie SMA Italy, Italian Telethon, and SMA Europe.

Giorgia Coratti received funding from Biogen, Roche, AveXis and Genesis Pharma as speaker in sponsored symposia.

Roberto de Sanctis received funding from Biogen as speaker in sponsored symposia.

Marika Pane received funding as a member of advisory boards from Biogen and AveXis and as speaker in sponsored symposia.

Richard S. Finkel Richard Finkel has received personal compensation for activities with Ionis Pharmaceuticals, Biogen, AveXis, Capricor, Catabasis, Lilly, Roche, Novartis; and the SMA Foundation, SMA Europe and Cure SMA as a consultant or advisor. Dr. Finkel has received research support from Ionis Pharmaceuticals, Biogen, Lilly, Cytokinetics Sarepta, NIH, MDA, and Summit.

Beatrice Berti, Lavinia Fanelli, Roberta Onesimo, Concetta Palermo, Daniela Leone, Sara Carnicella, Giulia Norcia, Nicola Forcina, Antonella Cerchiari, Valentina Giorgio, Simona Lucibello have nothing to disclose.

Figures

Fig. 1
Fig. 1
Individual details of the scores in the different subgroups according to severity highlighted by age range (0–5; 6–9; 10–24 months). The shaded areas corresponds to the maximum total score of the tool corresponding to what is expected in neurotypical infants.
Fig. 2
Fig. 2
Change in levels of impairment in the study cohort subdivided by SMA 1 decimal classification and visits: Each symbol corresponds to a single patient at each given age (open dot ○: no impairment; barred dot ø: mild impairment; grey dot •: moderate impairment; full dot •: severe impairment; the symbol –was used when an evaluation was not performed).
Fig. 3
Fig. 3
Correlation between total OrSAT checklist scores and age in different subgroups subdivided according to the OrSAT level of impairment. (○: no impairment; barred dot ø: mild impairment; grey dot \color grey•: moderate impairment; full dot •: severe impairment. Each symbol corresponds to a single patient. The shaded areas identify the maximum total OrSAT checklist score expected in typically developing infants at different ages (grey 0–5 months; Pink 6–9 months green: 10–24 months).

References

    1. D’Amico A, Mercuri E, Tiziano FD, Bertini E. Spinal muscular atrophy. Orphanet J Rare Dis. 2011;6:71. - PMC - PubMed
    1. Dubowitz V. Chaos in the classification of SMA: A possible resolution. Neuromuscul Disord. 1995;5(1):3–5. - PubMed
    1. De Sanctis R, Pane M, Coratti G, Palermo C, Leone D, Pera MC, et al.. Clinical phenotypes and trajectories of disease progression in type 1 spinal muscular atrophy. Neuromuscul Disord. 2018;28(1):24–8. - PubMed
    1. Finkel R, Bertini E, Muntoni F, Mercuri E, Group ESWS 209th ENMC International Workshop: Outcome Measures and Clinical Trial Readiness in Spinal Muscular Atrophy 7-9 November 2014, Heemskerk, The Netherlands. Neuromuscul Disord. 2015;25(7):593–602. - PubMed
    1. Mercuri E, Finkel RS, Muntoni F, Wirth B, Montes J, Main M, et al.. Diagnosis and management of spinal muscular atrophy: Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care. Neuromuscul Disord. 2018;28(2):103–15. - PubMed

Publication types